Analyse court terme - VIRBAC SA : Le retracement de 50% est atteint.
La résistance vient d'être franchie, la tendance devient positive puisque nous avons maintenant une succession de sommets et de creux ascendants. Le prochain objectif est à 140,00 €. Le niveau d'invalidation est sous 115,50 €.Arguments :
- Le retracement de 50% est atteint.
- La moyenne mobile sert de support.
- La réaction sur la résistance est faible, nous anticipons donc son franchissement prochain.
Virbac is an independent veterinary pharmaceutical laboratory. Co. develops and provides veterinarians and farmers with medicines and vaccines that improve the health of food producing animals. Co. markets a range of products designed for pets and livestock. It offers seven types of products for companion animals (Parasiticides, Immunology, Antibiotics/dermatology, Specialties, Equine, Specialized pet food and Other products), and four types of products for food producing animals (Bovine parasiticides, Bovine products (excluding parasiticides), Pig/poultry antibiotics and Other products). Co. markets its products in the ethical (veterinarian) and OTC markets.
DayByDay is an independent research company providing global macro and single stock analysis, recommendation and allocation based purely on behavioural finance methods. Those include long term cycle analysis, sentiment analysis, and technical trigger. DayByDay serves all clients in need of practical and precise publications to make effective market decisions, on any time horizon, from a few hours to a few years.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.